ZBH

NYSE

ZIMMER BIOMET HOLDINGS, INC.

Health Care, Health Care Equipment

$96.55

close 7 Aug 2026

-3.47%

52-week change

$18.42B

market cap

$79.12

$108.29

52-week range

Valuation

Market cap$18.42B

P/E (TTM / 5y avg)23.43x47.37x

Forward P/E (FY2026 / FY2027)11.32x10.65x

PEG (TTM / fwd)0.491.80

P/S (TTM)2.16x

P/B1.46x

EV/EBITDA (TTM)11.02x

FCF yield (TTM)8.27%

Cash flow & dividend

FCF (TTM)$1.52B

FCF per share (TTM)$7.98

FCF margin (TTM)17.90%

Dividend yield (indicated / 5y avg)0.99%0.87%

Annualized dividend$0.9600

Payout ratio (EPS / FCF)23.35%12.37%

Growth & quality

Revenue YoY, latest Q+4.80%

Diluted EPS YoY, latest Q+33.77%

Operating margin (TTM)14.16%

Net margin (TTM)9.48%

ROE (latest FY)5.55%

Net debt / EBITDA (TTM)3.06

Interest coverage (TTM)—

Price

-31.93%-7.43%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +6.08%10Y CAGR +3.22%

Diluted EPS

10Y CAGR +16.86%

FCF per share

5Y CAGR +10.44%10Y CAGR +7.89%

Operating cash flow

5Y CAGR +9.55%10Y CAGR +7.16%

Free cash flow

5Y CAGR +8.85%10Y CAGR +8%

Dividends per share

5Y CAGR +0.61%10Y CAGR +1.83%

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -1.44%10Y CAGR +0.10%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date3 Nov 2026bmo

EPS estimate$1.89

Revenue estimate$2.06B

Last reported

Date—

EPS——

Revenue——